IVY RX Review 2026
Reviewed August 7, 2026 · Both — compounded GLP-1 injections, microdose and oral melts, plus brand-name Ozempic and Mounjaro, alongside compounded peptides and supplements. Compounded products are not FDA-approved.
Visit IVY RX WebsiteOverview
IVY RX is a Miami-based longevity and weight-loss telehealth platform selling compounded GLP-1 injections at $97/month and a GLP-1 microdose at $77/month, alongside brand-name Ozempic and Mounjaro, oral GLP-1 melts, MIC + B12 injections, metformin and a broad anti-aging line covering NAD+, glutathione, B12 and sermorelin. On the weight-loss side it is priced competitively and thinks about the patient experience more than most: offering anti-nausea tablets as a companion product is a small thing that addresses the single most common reason people stop GLP-1 therapy, and having metformin available gives a non-GLP-1 route. It also publishes a physical address, a phone number and an email address, which sounds trivial until you notice how many competitors in this directory publish none of those. Two parts of the catalogue warrant caution rather than enthusiasm. IVY RX sells BPC-157, a peptide the FDA placed in Category 2 of its interim 503A bulk drug substances list in September 2023 — the category for substances that raise significant safety concerns and which the agency stated compounders would not be permitted to use. The FDA cited immunogenicity risk for certain routes of administration and difficulties characterising peptide impurities. The regulatory position on compounded peptides has been in flux during 2026, with the FDA removing some peptides from Category 2 in April 2026 and HHS signalling further change, so confirm the current status before buying. It also sells methylene blue and a 'GLP-1 Boost' supplement on wellness framing that the evidence does not carry.
Medications Offered
Brand-name or compounded: Both — compounded GLP-1 injections, microdose and oral melts, plus brand-name Ozempic and Mounjaro, alongside compounded peptides and supplements. Compounded products are not FDA-approved.
- GLP-1 Injection — $97
- GLP-1 Microdose — $77
- GLP-1 Oral Melts
- MIC + B12 Injection — $179
- Anti-Nausea Tablets — companion product for GLP-1 side effects
- Brand-name Ozempic® and Mounjaro®
- Metformin — non-GLP-1 oral option
- Anti-aging line: NAD+ injection and nasal spray, glutathione injection and nasal spray, B12 injection, sermorelin
- Supplements: BPC 157, GLP-1 Boost, Gut Peptide Complex, Methylene Blue
Consultation Process
Free consultation
IVY RX advertises a free consultation with fast approval and no insurance requirement, so establishing eligibility costs nothing.
Provider review
A provider reviews your information and determines treatment. No published eligibility criteria, BMI threshold or lab requirement is stated in advance.
Choose your format
The GLP-1 range spans standard injection, microdose and oral melts, plus brand-name Ozempic and Mounjaro — an unusually wide set of formats at this price point.
Free discreet delivery
Medication ships free and discreetly. Anti-nausea tablets can be added, which is a practical inclusion during titration.
Eligibility
- Adults; no published BMI threshold or age range
- Provider approval required after the free consultation
- No insurance required
- State availability is not published
- Standard GLP-1 contraindications apply
Provider Involvement
A free consultation with fast approval is advertised, and support is contactable by published phone and email — genuinely better access than most competitors, who offer a portal message form and nothing else. What is not published is any named clinical leadership, monitoring cadence or lab protocol.
Lab Requirements
Not published. Ask what baseline monitoring is expected before starting.
Pharmacy Fulfillment
Not named. IVY RX does not identify its compounding pharmacies or state their 503A or 503B status. That matters more than usual given the presence of BPC-157 in its catalogue, since the permissible status of that substance for compounding has been the subject of specific FDA action. Ask which facility prepares each product.
Shipping Frequency
Free and discreet delivery. Cadence and window not published.
Membership Fees vs. Medication Fees
Membership fees
None advertised. Products are priced individually per month.
Medication fees
- GLP-1 Injection: $97
- GLP-1 Microdose: $77
- MIC + B12 Injection: $179
- Other catalogue items observed at $19.99, $72 and $90
- Brand-name Ozempic and Mounjaro: pricing not shown on the pages we reviewed
- Consultation and delivery: free
Cancellation & Refund Policy
Cancellation
Not published. Since the platform has a published phone number and email, cancellation should at least be practically achievable — but get the process and any notice period confirmed in writing.
Refunds
Not published on the pages we reviewed.
Insurance
No insurance is required or billed. Brand-name Ozempic and Mounjaro are offered, which are in principle coverable on a pharmacy benefit — ask whether IVY RX can route a prescription to your own pharmacy if you have coverage.
HSA / FSA
Not stated. Confirm directly.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Free consultation with fast approval
- Published phone line, email address and physical address
- Free and discreet delivery
- Anti-nausea tablets available alongside GLP-1 treatment
State Availability
Not published. Confirm your state at the free consultation.
Pros
- GLP-1 injections at $97/month and a GLP-1 microdose option at $77/month
- Publishes a physical address, a phone number and an email — more contactability than most
- Offers brand-name Ozempic and Mounjaro alongside compounded options
- Includes anti-nausea tablets, which directly addresses the most common reason people quit
- Free consultation, free discreet delivery and no insurance required
- Metformin available as a non-GLP-1 alternative
- Claims 4.7 across 6,000+ reviews and 200,000+ patients
Cons
- Sells BPC-157, which the FDA placed in Category 2 of the interim 503A bulks list in September 2023 over safety concerns
- Also sells methylene blue and a 'GLP-1 Boost' supplement on wellness claims the evidence does not support
- Compounded GLP-1s are not FDA-approved
- No named compounding pharmacy
- No published cancellation policy, refund terms, state list, BMI criteria or lab requirements
- The 4.7 rating and patient count are not linked to a verifiable external platform
Who IVY RX May Be Best For
- Price-driven buyers who want a microdose option and a companion anti-nausea product
- People who value being able to phone a provider rather than only message a portal
Limitations
- BPC-157 in the catalogue, with a contested regulatory status
- Supplement range sold on unevidenced claims
- No named pharmacy, refund policy, cancellation terms, states or eligibility criteria
- Claimed ratings not externally verifiable
Reputation & Trust
A competitively priced weight-loss offering wrapped in a supplement catalogue that needs more scepticism than the marketing invites. On the positive side, IVY RX publishes a physical address in Miami, a phone number and an email — basic contactability that a surprising number of competitors omit entirely — offers brand-name alongside compounded product, includes anti-nausea tablets that address the main reason patients discontinue, and provides metformin as a non-GLP-1 route. Claimed metrics of 4.7 across 6,000-plus reviews and 200,000-plus patients are substantial, though not linked to a verifiable external platform. The concern is BPC-157. The FDA placed that peptide in Category 2 of its interim 503A bulk drug substances list in September 2023, stating it raises significant safety concerns and that compounders would not be permitted to use it, citing immunogenicity risk for certain routes and difficulty characterising peptide impurities. The 2026 position has been unsettled — the FDA removed a number of peptides from Category 2 in April 2026 and HHS has signalled further change — so we are not asserting the current legal status, but a prospective buyer should establish it rather than assume. Methylene blue and a 'GLP-1 Boost' supplement round out a wellness range sold on claims well ahead of the evidence.
What Makes IVY RX Different
- $77 microdose and $97 standard GLP-1 pricing
- Anti-nausea tablets offered alongside GLP-1 treatment
- Brand-name Ozempic and Mounjaro on the same platform
- Published address, phone and email
- Four GLP-1 formats including oral melts
Our Verdict
IVY RX earns 3.5/5. Its weight-loss offering is well judged and competitively priced: $97 for a compounded GLP-1 injection, $77 for a microdose, oral melts for the injection-averse, brand-name Ozempic and Mounjaro for those who want approved product, metformin as a non-GLP-1 route, and — a genuinely thoughtful inclusion — anti-nausea tablets that address the most common reason people abandon treatment. It publishes a Miami address, a phone number and an email, which sounds unremarkable until you notice how many competitors in this directory publish none of them. Where we would apply the brakes is the surrounding catalogue. IVY RX sells BPC-157, a peptide the FDA placed in Category 2 of its interim 503A bulks list in September 2023 over immunogenicity and impurity concerns, stating compounders would not be permitted to use it — a position that has been unsettled through 2026 but which a buyer should establish rather than assume. Methylene blue and a 'GLP-1 Boost' supplement sit on the same shelf with similarly thin support. The usual gaps apply too: no named pharmacy, no refund or cancellation terms, no state list. Buy the weight-loss products, ask questions about the rest.
Alternatives to IVY RX
Similar pricing from $86/month with published 50-state coverage.
Full formulary with the clearest efficacy and fee disclosure in this directory.
Comparable price bracket with far better regulatory and billing disclosure.
If microdosing is the draw, clearer published pricing and eligibility guidance.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
What does IVY RX cost?
GLP-1 injections are published at $97/month and the GLP-1 microdose at $77/month, with MIC + B12 injections at $179. The consultation and delivery are free and no insurance is required. Brand-name Ozempic and Mounjaro are offered but their prices were not shown on the pages we reviewed.
Should I buy BPC-157 from IVY RX?
We would establish its current regulatory status first. In September 2023 the FDA placed BPC-157 in Category 2 of its interim 503A bulk drug substances list — substances that raise significant safety concerns and which the agency said compounders would not be permitted to use — citing immunogenicity risk for certain routes of administration and difficulty characterising peptide impurities. The position has been unsettled through 2026, with some peptides removed from Category 2 in April 2026. Ask IVY RX directly what the current status is and which pharmacy compounds it, and discuss it with an independent clinician.
Is IVY RX's GLP-1 medication FDA-approved?
The compounded versions are not. Compounded GLP-1 injections, microdoses and oral melts have not been evaluated by the FDA for safety, efficacy or quality and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound beyond the shared active ingredient. The brand-name Ozempic and Mounjaro it also offers are FDA-approved.
Are the anti-nausea tablets worth adding?
Possibly, and it is a sensible thing to offer. Nausea is the most common reason people discontinue GLP-1 therapy, particularly during titration, so a provider that anticipates it is thinking about retention as a clinical problem rather than just a billing one. Discuss with the prescriber which anti-emetic is appropriate for you and whether it interacts with anything else you take.
What about the methylene blue and GLP-1 Boost supplements?
We would treat both sceptically. They are sold on general wellness framing without published evidence supporting the benefits implied, and neither is FDA-approved for the uses suggested. Nothing in this range is necessary to a GLP-1 programme.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult a licensed clinician before starting or changing treatment.
- BPC-157: the FDA placed this peptide in Category 2 of its interim 503A bulks list in September 2023, citing significant safety concerns including immunogenicity risk and impurity characterisation difficulties. The 2026 position has been in flux — confirm the current regulatory status and speak to an independent clinician before purchasing.
- Compounded GLP-1 products are NOT FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound beyond the shared active ingredient.
- Methylene blue and 'GLP-1 Boost' supplements are sold on claims the evidence does not support.
- No compounding pharmacy is named — ask which facility prepares each product and its 503A status.
- No refund policy, cancellation terms, state list or eligibility criteria is published.
- GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2, and in pregnancy.
- Common side effects include nausea, vomiting, diarrhoea, constipation and abdominal pain; serious risks include pancreatitis, gallbladder disease and kidney injury from dehydration.
Sources
- IVY RX product and collection pages, ivyrx.com (accessed 7 August 2026)
- FDA, 'Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks' — BPC-157 placed in Category 2 of the interim 503A bulks list, September 2023
- Reporting on the FDA's April 2026 removal of certain peptides from Category 2 of the interim 503A bulks list
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.